Livalo (pitavatstatin) tablets, 4 mg, 90-count bottles, Rx only, Manufactured by: Patheon, Inc. C...

FDA Recall #D-0258-2025 — Class III — February 24, 2025

Recall #D-0258-2025 Date: February 24, 2025 Classification: Class III Status: Completed

Product Description

Livalo (pitavatstatin) tablets, 4 mg, 90-count bottles, Rx only, Manufactured by: Patheon, Inc. Cincinnati, OH 45237 USA or by Kowa Company, Ltd, Nagoya, 462-0024 Japan, Marketed by Kowa Pharmaceuticals: Kowa Pharmaceuticals America Inc., Montgomery, AL 36117 USA NDC 66869-404-90 HDPE Bottle, congregated into a shrink wrapped 6-pack further congregated into 24 6-packs in a cardboard case

Reason for Recall

Presence of foreign tablets/capsules

Recalling Firm

Kowa Pharmaceuticals America — Montgomery, AL

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

5,328 Bottles

Distribution

PA, OH, and TX

Code Information

Lot#: 3231300, Exp 8/2027

Status

Completed

Voluntary / Mandated

Voluntary: Firm initiated